sGCalphal inhibiting compositions
The present invention provides materials and methods useful to treat various sGCα1-expressing cancers. Materials include peptides which interfere with sGCα1's pro-survival functions, thereby resulting in apoptosis of sGCα1-expressing cells. In addition, the present invention provides screening assays, diagnostic assays, methods to prognose, methods to treat, and kits.
1. A composition of matter comprising a peptide consisting of the amino acid sequence of FF5-8R (SEQ ID NO: 10).
2. A pharmaceutical composition comprising: a composition of claim 1 ; and a pharmaceutically-acceptable carrier.
3. A composition of claim 1 , further comprising a chemotherapeutic agent.
4. A composition of claim 3 , wherein the chemotherapeutic agent is etoposide.